KFRC.NYSEKforce INC

Form 4: Kforce CEO Joseph Liberatore Receives Restricted Stock Grant

Sentiment:

Insider Transaction Report


Kforce Inc. CEO Joseph J. Liberatore was granted 104,059 shares of restricted common stock, vesting annually starting December 27, 2026.

Summary

  • Joseph J. Liberatore, President & CEO and Director of Kforce Inc. (KFRC), acquired 104,059 shares of common stock.
  • The transaction date for this acquisition was December 31, 2025.
  • The shares acquired are restricted stock, granted at a price of $0 per share.
  • These restricted shares will vest at a rate of 33% annually, beginning on December 27, 2026.
  • Following this transaction, Mr. Liberatore beneficially owns 335,527 shares of common stock.
  • The total beneficial ownership includes 216,213 shares of restricted stock.

Sentiment

Score: 7

Explanation: The grant of restricted stock to the CEO is a positive event, aligning management's interests with shareholders and serving as a retention tool. It's a routine compensation event, not indicative of extraordinary company performance or issues, hence a moderately positive score.

Positives

  • The grant of restricted stock aligns the interests of the CEO with those of the shareholders, incentivizing long-term performance.
  • The transaction represents a significant equity award to a key executive, reflecting confidence in his continued leadership.

Negatives

  • The shares are restricted and do not provide immediate liquidity to the executive.
  • The vesting schedule means the full benefit of the grant is realized over several years, subject to continued employment.

Risks

  • NA

Future Outlook

The acquired restricted stock will vest annually at a rate of 33% starting December 27, 2026, indicating a multi-year incentive structure for the CEO.

Industry Context

Executive compensation through restricted stock grants is a standard practice across various industries, particularly in professional services and staffing, to retain key talent and align leadership incentives with long-term shareholder value.

Comparison to Industry Standards

  • The grant of restricted stock at a $0 price is a common method for executive compensation, similar to practices seen in other publicly traded companies within the professional staffing and solutions sector.
  • The multi-year vesting schedule (33% annually) is typical for long-term incentive plans, comparable to those offered by peers like Robert Half International (RHI) or Kelly Services (KELYA) for their senior executives, designed to promote retention and sustained performance.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Disclosure of 10b5-1 PlanThe transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).12/31/2025Indicates a pre-arranged trading plan, which enhances transparency and helps mitigate concerns about insider trading.

Related Party Transactions

  • The acquisition of restricted stock by Joseph J. Liberatore, the President & CEO and a Director, constitutes a related party transaction as it involves a key executive and the company.

Stakeholder Impact

  • Shareholders: The grant of restricted stock to the CEO is intended to align his long-term interests with shareholder value creation.
  • Employees: May signal stability in leadership and a commitment to executive retention.

Next Steps

  • The restricted stock will begin its annual vesting schedule on December 27, 2026.

Key Dates

DateDescription
12/31/2025Date of earliest transaction for the acquisition of restricted stock.
01/05/2026Date the Form 4 was signed by the attorney-in-fact for Joseph J. Liberatore.
12/27/2026Date when the restricted stock begins to vest at an annual rate of 33%.

Recommendation

hold

This Form 4 reports a routine executive compensation event (restricted stock grant) and does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It primarily serves to align executive incentives with long-term shareholder value.

Keywords

Kforce, KFRC, Joseph J. Liberatore, Restricted Stock, Stock Grant, Executive Compensation, Insider Transaction, Form 4, Equity Award

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.